Daytrana Approval History
FDA Approved: Yes (First approved April 6, 2006)
Brand name: Daytrana
Generic name: methylphenidate
Dosage form: Transdermal System
Previous Name: MTS
Company: Shire Pharmaceuticals Group plc / Noven Pharmaceuticals, Inc.
Treatment for: ADHD
Daytrana is a once daily transdermal patch formulation of methylphenidate indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
Development History and FDA Approval Process for Daytrana
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.